Harrow Health Inc
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE; MAXITROL eye drops; ILEVRO and NEVANAC, … Read more
Harrow Health Inc (HROW) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.356x
Based on the latest financial reports, Harrow Health Inc (HROW) has a cash flow conversion efficiency ratio of 0.356x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($16.59 Million) by net assets ($46.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Harrow Health Inc - Cash Flow Conversion Efficiency Trend (2005–2024)
This chart illustrates how Harrow Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Harrow Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Harrow Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tikehau Capital
PINK:TKKHF
|
-0.143x |
|
PROPETRO HLD.CORP.DL-001
F:2PG
|
N/A |
|
BUMI RESOURC.MINER.RP 625
F:BUR
|
N/A |
|
Rémy Cointreau SA
PINK:REMYF
|
0.002x |
|
Hyundai Construction Equipment Co Ltd
KO:267270
|
0.045x |
|
Forehope Electronic (Ningbo) Co. Ltd. A
SHG:688362
|
N/A |
|
Boai NKY Pharmaceuticals Ltd
SHE:300109
|
0.038x |
|
Shandong Dongyue Organosilicon Mat
SHE:300821
|
0.023x |
Annual Cash Flow Conversion Efficiency for Harrow Health Inc (2005–2024)
The table below shows the annual cash flow conversion efficiency of Harrow Health Inc from 2005 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $69.30 Million | $-22.20 Million | -0.320x | -684.06% |
| 2023-12-31 | $70.00 Million | $3.84 Million | 0.055x | -13.50% |
| 2022-12-31 | $26.89 Million | $1.71 Million | 0.063x | -86.36% |
| 2021-12-31 | $10.93 Million | $5.08 Million | 0.465x | +1233.89% |
| 2020-12-31 | $26.83 Million | $-1.10 Million | -0.041x | -218.34% |
| 2019-12-31 | $27.42 Million | $950.00K | 0.035x | +24.83% |
| 2018-12-31 | $24.75 Million | $687.00K | 0.028x | +100.82% |
| 2017-12-31 | $2.62 Million | $-8.80 Million | -3.366x | -93.07% |
| 2016-12-31 | $6.43 Million | $-11.21 Million | -1.744x | -121.67% |
| 2015-12-31 | $-1.39 Million | $-11.14 Million | 8.045x | +1029.39% |
| 2014-12-31 | $8.15 Million | $-7.06 Million | -0.866x | -194.69% |
| 2013-12-31 | $15.11 Million | $-4.44 Million | -0.294x | -54.49% |
| 2012-12-31 | $10.00 Million | $-1.90 Million | -0.190x | -211.02% |
| 2011-12-31 | $-1.70 Million | $-291.16K | 0.171x | -92.26% |
| 2010-12-31 | $-1.04 Million | $-2.30 Million | 2.214x | +135.78% |
| 2009-12-31 | $577.21K | $-3.57 Million | -6.186x | -1016.35% |
| 2008-12-31 | $4.57 Million | $-2.53 Million | -0.554x | -9.67% |
| 2007-12-31 | $3.49 Million | $-1.76 Million | -0.505x | +82.02% |
| 2006-12-31 | $21.35K | $-60.00K | -2.810x | -145.49% |
| 2005-12-31 | $34.99K | $-40.06K | -1.145x | -- |